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HPV late gene expression is initiated as an infected basal cell migrates through the differentiating layers of the epidermis,
resulting in the onset of vegetative viral DNA replication and the expression of viral late proteins. We have used a large
synthetic immunoglobulin library displayed on phage (diversity 6.5 1 1010 phage) to isolate three Fabs (TVG405, 406, and
407) which recognize distinct epitopes on the E4 late protein of HPV16. A C-terminal monoclonal (TVG404) was generated
by hybridoma technology, and N-terminal polyclonal antiserum was prepared by peptide immunization (a N-term). The most
potent antibody (TVG405) had an affinity for E4 of approximately 1.0 nM. All antibodies recognized the protein in paraffin-
embedded archival material, allowing us to map events in the late stages of virus infection. Expression of E4 in vivo does not
coincide with synthesis of the major virus coat protein L1, but precedes it by 1 or 2 cell layers in premalignant lesions caused
by HPV16 and by up to 20 cell layers in HPV63-induced warts. In higher grade lesions associated with HPV16, E4 is produced
in the absence of L1. By contrast, vegetative viral DNA replication and E4 expression correlate exactly and in some lesions
begin as the infected epithelial cell leaves the basal layer. Differentiation markers such as filaggrin, loricrin, and certain
keratins are not detectable in E4-positive cells, and nuclear degeneration is delayed. HPV16 E4 has a filamentous distribution
in the lower epithelial layers, but associates with solitary perinuclear structures in more differentiated cells. Antibodies to the
N-terminus of the protein stained these structures poorly. Our findings are compatible with a role for the HPV16 E4 protein
in vegetative DNA replication or in modifying the phenotype of the infected cell to favor virus synthesis or virus release. The
Fabs will be of value in the evaluation of model systems for mimicking HPV infection in vitro. q 1997 Academic Press
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Studies on naturally occurring warts have revealedINTRODUCTION
the virus to encode three late proteins— L1 and L2,
Papillomaviruses (PVs) cause epithelial tumors in hu- which are virion coat proteins (Doorbar and Gallimore,
mans which vary in severity depending on the site of 1987), and E1 ò E4, a nonstructural late protein of un-
infection and the HPV type involved (Laimins, 1993; de known function (Doorbar et al., 1986). The abundance of
Villiers, 1994). Low-risk types such as HPV 1 or HPV63 E1 ò E4 in HPV1-induced warts (Breitburd et al., 1987;
(Egawa et al., 1993a,b) cause benign cutaneous warts Doorbar et al., 1986) and the availability of well-charac-
which progress to malignancy only rarely, while high-risk terized antibodies (Doorbar et al., 1988) (Mabs) have
viruses such as HPV 16 and HPV31 cause flat warts at allowed the protein to be extensively characterized in
mucosal sites and are associated with high-grade cervi- vivo. The HPV1 E1ò E4 protein is first expressed in cells
cal intraepithelial neoplasia (CIN) and cancer (Schneider, of the lower spinous layer and assembles into distinctive
1994). Formation of an HPV-induced tumor is thought cytoplasmic and nuclear inclusions. During terminal dif-
to require infection of an epithelial basal cell and the ferentiation it is posttranscriptionally modified by phos-
expression of viral early proteins in order to stimulate phorylation (Grand et al., 1989) and by removal of se-
cell proliferation. The late stages of the virus life cycle, quences from the N-terminus (Doorbar et al., 1988; Rob-
which ultimately lead to the production of infectious viri- erts et al., 1994). By contrast, the E1 ò E4 proteins of
ons, are initiated only as the infected cell migrates high-risk viruses are poorly characterized, largely be-
through the upper differentiated layers of the epidermis. cause many HPV16-induced lesions contain only small
Viral and cellular events which influence HPV late gene numbers of productively infected cells, which contain
expression are only poorly understood because until re- relatively low levels of E4 (Doorbar, 1996; Doorbar and
cently there has been no convenient system for mimick- Myers, 1996). A single Mab to HPV16 E1 ò E4 has been
ing productive infection in vitro (Laimins, 1993). used to localize the protein to the cytoplasm (TVG 402)
but has been reported not to work well on paraffin-em-
bedded archival material (Doorbar et al., 1992). Poly-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: /44 (0) 181 906 4477. E-mail: jdoorba@nimr.mrc.ac.uk. clonal antibody studies have yielded conflicting results.
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One study has supported the above findings (Crum et transferred from the isolated phage into the bacterial
al., 1990), while another has indicated that the protein expression vector pUC119.His.myc (Griffiths et al., 1994),
is localized to the nucleus (Palefsky et al., 1991), sug- and soluble Fabs were purified from the periplasmic
gesting that different forms of the protein may have dif- space of induced bacteria by nickel-NTA chromatogra-
ferent distributions. phy (Qiagen, Crawley, UK). Antibody titers were estab-
Here we have generated five new epitope-mapped an- lished by ELISA.
tibodies to the HPV16 E4 protein using a combination
Epitope mapping of antibodies using overlappingof phage display technology, hybridoma production, and
peptidesimmunization of mice using synthetic peptides. Using
these reagents we have characterized the E4 protein of The HPV16 E4 protein was synthesized as a series of
HPV16 and its associated structures in vivo and have 85 overlapping octomers (single amino acid overlap) by
correlated its expression with events in the late stages solid-phase fmoc chemistry using the SPOTS epitope
of papillomavirus infection. These results show that ex- mapping system (Genosys Biotechnologies, Cambridge,
pression of E4 coincides almost exactly with the onset UK). Accuracy of synthesis was confirmed using the
of vegetative viral DNA replication but not with virus syn- HPV16 E1 ò E4 monoclonal TVG402 which binds the
thesis and that cells expressing E4 lack normal markers major antigenic site of the protein (Doorbar et al., 1992).
of terminal differentiation. Filters were regenerated as described by the manufac-
turers and antibody binding was visualized by ECL (Am-
MATERIALS AND METHODS ersham, Little Chalfont, UK). Polyclonal serum was used
at 1/250 dilution, purified Fabs were used at approxi-Production of monoclonal and polyclonal antibodies
mately 1 mg/ml, and hybridoma supernatant was used atby immunization
1/10 dilution.
Monoclonal antibody TVG404 which recognized an
Measurement of antibody affinities by surfaceepitope at the very C-terminus of E4 was prepared by
plasmon resonancestandard hybridoma technology as described previously
(Doorbar et al., 1992). Antibodies to the N-terminus of Affinities of synthetic (TVG405, TVG406, and TVG407),
the protein were raised against the synthetic peptide and hybridoma-derived Fabs (TVG402) were analyzed by
MADPAAATKYPLC after conjugation to thyroglobulin or surface plasmon resonance using a Biacore 2000 (Phar-
keyhole limpet hemocyanin through its C-terminal cystein macia Biosensor, St. Albans, UK) as described by the
residue. Conjugation was carried out using m-maleimi- manufacturer. MBP-E4 aggregates were dissociated un-
dobenzoyl-N-hydroxysuccinimide ester (MBS) as de- der reducing conditions in 0.5% SDS, 1 mM b-mercapto-
scribed by Green et al. (1982). Polyclonal antibodies (to ethanol, 50 mM Na2CO3/NaHCO3 (pH 8.5) and biotinyl-
HPV16 and HPV63 E4 proteins) were prepared by immu- ated using NHS-LC–biotin (Sigma, St. Louis, MO; 25 mg/
nization of rabbits with maltose-binding protein E4 fusion ml in DMSO) at a biotin:protein molar ratio of 6:1 (Johnson
protein (MBP-E4). Antibody titers were monitored in et al., 1991). Monomeric MBP-E4 was recovered by FPLC
ELISA using purified glutathione S-transferase E4 fusion chromatography using a Superdex S200 HR10/30 column
protein (GST-E4). run in 6 M urea/1 mM b-mercaptoethanol/PBS/0.2 mM
EDTA (pH 7.2), before being bound to a streptavidin-
Selection of synthetic Fabs by in vitro selection coated sensor chip and ‘‘refolded in vitro’’ in PBS/0.2 mM
EDTA/0.1 mg/ml protease-free BSA (Sigma). Fabs wereFabs were isolated from a synthetic antibody displayed
isolated from purified TVG402 using an Immunopure Fabon fd bacteriophage (Griffiths et al., 1994) as described
kit (Pierce, Rockford, IL), and monomeric preparationsbelow. Immunotubes (Life Technologies, Paisley, UK)
were obtained by FPLC gel chromatography (Superdexwere coated overnight at 47 with either MBP-E4 or GST-
S200 HR10/30 column run in PBS/0.2 mM EDTA (pH 7.2)).E4 at a concentration of 0.1 mg/ml. These were subse-
Sensor chip surfaces were regenerated using 6 M ureaquently blocked at 377 for 1 hr in PBS/2% marvel prior to
column buffer (described above). On and off rates wereincubation in the presence of 1011 phage on a blood tube
derived by nonlinear curve fitting using the proprietaryrotator (377). Unbound phage were poured off, and tubes
BIAanalysis software.were washed 101 with PBS/0.1% Tween 20. Binders
were eluted with 100 mM triethylamine, pH 11.0 (1 ml),
Detection of proteins by immunofluorescence
and immediately neutralized with 1 M Tris (pH 8.0) before
being reintroduced into Escherichia coli TG1 cells. The Immunofluorescence was carried out on 5-mm sec-
tions of formalin-fixed paraffin-embedded tissueenriched library was grown and the selection procedure
repeated three more times. Phage displaying antibodies mounted on Apes-coated microscope slides (Adden-
brookes Hospital, Cambridge, UK). Eight CIN1 and five CINwith affinity for E4 were identified by ELISA (against GST-
E4, MBP-E4, GST, and MBP), and activity was confirmed 2 lesions associated with HPV16 were examined. Three
HPV1-associated lesions and two associated with HPV63by phage Western blotting. Immunoglobulin genes were
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were investigated (one kindly provided by K. Egawa, Kumo- guidelines and detected using an anti-digoxigenin alka-
line phosphatase conjugate using bromochloroindolylmoto Medical School, Japan). Antibodies were used at the
concentrations described for epitope mapping (outlined phosphate/nitro blue tetrazolium as described by the
manufacturers (Boehringer Mannheim). E4 staining wasabove) and were detected using anti-mouse or anti-rabbit
secondary antibodies conjugated to fluorescein isothiocya- carried out on the developed slides using a mixture of
anti-E4 reagents (TVG402, 405, 406 for HPV16 and 4.37nate (FITC) or Texas red (TR). Nuclei were counterstained
with 0.001% 4*,6*-diamidino-2-phenylindole (DAPI). Syn- and 9.95 for HPV1) followed by the appropriate FITC con-
jugate.thetic Fabs were detected using mouse monoclonal 9E10,
which recognizes the myc tag (present on the synthetic
Fabs) (Boehringer Mannheim, Lewes, UK), reagents di- RESULTS
rected against the His tag (e.g., Ni-NTA peroxidase conju-
Generation of epitope defined monoclonal andgate; Qiagen, Crawley, UK), or secondary antibodies to
polyclonal antibodies by immunization in vivohuman light chains (e.g., anti-k/l light chain conjugates,
The Binding Site, Birmingham, UK). For immunofluores- Although Mabs against HPV16 E1 ò E4 have been
cence studies on human tissue, monoclonal 9E10 was described previously ((TVG401, 402, 403) (Doorbar et al.,
used as the second step followed by immunofluorescent 1992)), these reagents recognize a single overlapping
detection with anti-mouse conjugate. epitope at the major antigenic site of E4 and have been
For double-staining, synthetic Fabs were purified by reported not to detect the protein in archival tissue biop-
Ni-NTA affinity chromatography and directly labeled us- sies (Doorbar et al., 1992). Attempts to generate further
ing fluorescein-EX succinimidyl ester or Texas red-X suc- Mabs by standard hybridoma technology resulted in the
cinimidyl ester (Molecular Probes, Eugene, OR). TVG402 isolation of TVG 404, an IgM which recognized an epitope
was purified from hybridoma supernatant by Protein A at the very C-terminus of the protein. To complement this
affinity chromatography and labeled in the same way. reagent, polyclonal antiserum to the N-terminus of the
Antibodies to specific keratins (LHK1/LL017, keratin 1; protein was raised against an N-terminal synthetic pep-
LH2, keratin 10; 6B10, keratin 4; 2D7, keratin 13) and tide (a-E4 N term). Antibody specificities were confirmed
involucrin (Hudson et al., 1992) were generously provided by epitope mapping (see Materials and Methods), and
by Irene Leigh (Dept. Dermatology, Queen Mary and the results are summarized in Fig. 1. Our difficulties in
Westfield College, London). Filaggrin antibodies were isolating high-affinity Mabs to epitopes outside the major
obtained commercially (Biogenesis, Bournemouth, UK). antigenic region of E4 led us to use a synthetic immuno-
L1 staining was carried out either using the Camvir 1 globulin repertoire displayed on phage. Such libraries
monoclonal which recognizes HPV16 L1 (McClean et al., are not influenced by clonal deletion and anergy that
1990) or using cross-reactive anti-BPV1 polyclonal serum result in self-tolerance in vivo and contain binding speci-
(Dako Ltd., High Wycombe, USA). For double stains, the ficities not present in the natural B-cell repertoire.
antibody requiring the secondary conjugate was used
first. Fluorescent detection was completed by adding the In vitro generation of epitope mapped antibodies
secondary conjugate before the directly conjugated anti- using a synthetic immunoglobulin repertoire
E4 Fab was added. Immunofluorescence staining was displayed on phage
enhanced by microwave treatment and was used in
some instances. Sections were dewaxed as normal and High-affinity antibodies (10 nM) can be isolated di-
rectly from synthetic immunoglobulin repertoires of suffi-microwaved on full power (750-W oven) in 500 ml of 0.01
M citrate buffer (pH 5.0) for 15 min. After cooling for 20 – ciently large size and diversity (Griffiths et al., 1994).
Phage selections were carried out alternately against30 min sections were washed in PBS and blocked in
10% FCS prior to staining. GST 16 E1 ò E4 and MBP 16 E1 ò E4 in order to prevent
isolation of antibodies to MBP or GST protein, using a
repertoire of 6.5 1 1010 Fabs (Griffiths et al., 1994). Al-Detection of vegetative viral DNA replication by in
though MBP 16 E4 was expressed at higher levels (50situ hybridization
mg/liter of bacteria) than the GST fusion (approx. 5 mg/
liter of bacteria) antibody isolation requires as little as 1DNA in situ hybridization was carried out using HPV16
DNA which had been separated from the pBR322 cloning mg of antigen (Hawkins et al., 1992). After four rounds of
selection, individual clones were examined for their abil-vector by BamHI digestion and gel electrophoresis and
purified using GeneClean (Anachem, Luton, UK). HPV18, ity to bind E1 ò E4, unfused GST or MBP, or bovine
serum albumin (BSA). Forty-seven clones (of 100) wereHPV11, and HPV6 DNAs were released from their paren-
tal vector by digestion with EcoRI, BamHI, and EcoRI, able to bind MBP 16 E1 ò E4, 39 of which could also
bind GST 16 E4. None of these clones interacted withrespectively, and used for initial typing and as controls.
DNA was labeled by the random primer method using BSA, GST, or MBP. BstNI fingerprinting (Marks et al.,
1992; Nissim et al., 1994) revealed three distinct Fabsdigoxigenin-labeled deoxyuridine-triphosphate. Hybrid-
ization was carried out according to the manufacturers’ among these clones, and their immunoglobulin genes
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FIG. 1. Location of epitopes on the E1 ò E4 protein of HPV16. (A) The sequences of the 85 overlapping E4 synthetic peptides are shown at the
top of the figure, and the results of the epitope mapping experiments are shown at the bottom. The dark spots represent binding of the antibody to
the synthetic peptide shown above it. Only the portion of the filter containing peptides which reacted with each antibody are shown. (B) The location
of epitopes on the E1 ò E4 amino acid sequence are summarized above the HPV16 sequence. Alignment with a consensus E4 sequence prepared
by comparison of 70 putative E1 ò E4 sequences (Doorbar and Myers, 1996) is shown below the sequence of HPV16 E1 ò E4, and the sequence
of the HPV1 E1 ò E4 protein is shown below this. The binding sites of the existing HPV1 E1 ò E4 Mabs (Doorbar et al., 1988) are shown beneath
the HPV1 sequence. The proteolytic cleavage sites that give rise to the 16K and 10/11K gene products in the E1 ò E4 protein of HPV1 (Doorbar et
al., 1988; Roberts et al., 1994) are indicated below the HPV1 sequence, allowing prediction of putative sites in the E1 ò E4 sequence of HPV16.
were subcloned into the prokaryotic expression vector 407 displayed rapid kinetics and were thus examined by
Scatchard analysis of equilibrium binding data, as shownpUC119His.6myc to allow the production of soluble anti-
E4 Fabs (Griffiths et al., 1994). Approximately 5 mg (per for TVG407 (Figs. 2c and 2d; see legend for further de-
tails). TVG407 had an affinity (Kd) of 50 nM after correctionliter of bacteria) of anti-E4 Fab (TVG 405, 406, and 407)
could be extracted from the periplasmic space of induced for biological activity, and TVG406 had an affinity (Kd) of
28 nM (data not shown). The amino acid sequences ofbacteria and all were found to specifically detect E1 ò
E4 by ELISA and Western blotting. Fab TVG 407 bound the heavy and light chain CDR3 loops were established
by DNA sequencing (data not shown), further confirmingan epitope which was identical to that recognized by the
hybridoma-derived Mab, TVG 402 (Fig. 1). The remaining that the three antibodies were distinct.
synthetic Fabs recognized novel epitopes upstream (TVG
E4 late gene expression precedes virus synthesis to405) or downstream (TVG 407) of this major antigenic
varying extents in low- and high-grade mucosalregion of E4, and the results are summarized in Fig. 1.
lesions caused by HPV16 and in benign cutaneous
lesions caused by HPV1 and HPV63The highest affinity antibodies to HPV16 E4 proteins
were obtained by selection of the synthetic
All the synthetic Fabs detected the HPV16 E1 ò E4
repertoire in vitro
protein in formalin-fixed paraffin-embedded tissue, al-
though TVG405 consistently showed the highest level ofAffinities of Fab fragments for MBP-E4 were measured
by surface plasmon resonance using purified monomeric staining (Fig. 3). Epitope exposure by microwave treat-
ment enhanced the sensitivity of E4 detection and evenFabs. Binding activities were on the order of 20% of total
protein levels for the bacterially derived antibodies and allowed staining using TVG402 (Doorbar et al., 1992). The
extent of E4 expression varied greatly between different50% for Fabs derived from hybridoma culture superna-
tant. The affinities of TVG405 and TVG402 were calcu- lesions (eight HPV16-associated CIN1 biopsies were ex-
amined), ranging from expression only in rare cells scat-lated from on and off rates obtained by nonlinear curve
fitting to sets of BIAcore binding curves (Figs. 2a and tered throughout the biopsy (Fig. 3) to widespread distri-
bution throughout the most differentiated layers of the2b). TVG405 had an association rate constant (kon) of 1.8
1 106 M01rs01 and an off rate (koff) of 21 103 s01, indicat- epidermis (Fig. 4) comparable to the distribution of E4 in
cutaneous warts caused by HPV1 and HPV63 where theing a molar dissociation constant (Kd) of approximately 1
nM. The best hybridoma-derived antibody—TVG402 — production of infectious virions is also high (Fig. 4). In low-
grade cervical intraepithelial neoplasia (CIN 1) caused byhad an affinity of only 70 nM and had a kon of 4.2 1 104
M01rs01 and a koff value of 3 1 103 s01. TVG 406 and HPV16, E4 and L1 levels were also found to correlate
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FIG. 2. Measurement of affinities by surface plasmon resonance. (A) Overlay of binding curves (sensograms) obtained after passing Fab TVG405
over a biacore chip coated with MBP–E4 fusion protein as described in the text. Fab concentrations ranged from 10 nM (lowest curve) to 300 nM
(upper curve) through five intermediate dilutions. The extent of binding is indicated in resonance units on the X axis, against time in seconds on the
Y axis. Purified Fab was injected at around 100 sec and washing initiated at 700 sec. The affinity (Kd) of TVG405 was calculated as between 0.3 and
1.25 nM by analysis of the association and dissociation curves using BIAevaluation software (Pharmacia, UK). (B) Overlay of binding curves (as
described above) for the hybridoma-derived Fab TVG402 over a concentration range 100 nM to 1 mM. The Kd was estimated as 70 nM. (C) Equilibrium
binding curve of Fab TVG407, which displayed rapid kinetics. (D) Scatchard analysis of the data presented in C using BIAevaluation software. Equilibrium
values were corrected for bulk refractive index changes by subtracting values from a surface blocked with biotin, from the values shown in C. In the
plot shown the slope is 0Kd and the Y-axis intercept is Rmax , i.e., the binding level at saturation with Fab. The uncorrected Kd values for TVG407 and
TVG406 were 250 and 140 nM, which, when the activity of the Fab preparation was considered, indicated actual affinities of 50 and 28 nM.
closely, although expression of the two proteins was not warts, vegetative viral DNA replication and E4 synthesis
commence much earlier and are evident immediatelycoincident (as previously suggested by Brown et al.
(1994)). E4 expression preceded the synthesis of the ma- after the infected basal cell migrates into the superficial
layers (Fig. 5). Only a proportion of the differentiating cellsjor capsid protein by several cell layers (as revealed by
double-staining, see Fig. 4) and in high-grade cervical were permissive for vegetative viral DNA replication, and
only in these cells was E4 detectable. Neighboring cellslesions (CIN 2/CIN 3), E4 was often abundant, even
though the expression of L1 was no longer supported showed neither late gene expression nor vegetative viral
DNA replication, suggesting that onset of the two events(Fig. 4). This time delay between the commencement of
E4 synthesis and the assembly of infectious virions was is closely linked. Although the sensitivity of DNA and E4
detection was not established, these ‘‘normal’’ cells aremost apparent in HPV63, where E4 expression coincided
with migration of an infected basal cell into the parabasal likely to be either nonpermissive for viral replication or
uninfected. This precise correlation between E4 expres-layers, while expression of L1 was restricted to a narrow
strip of cells in the upper granular layer. sion and onset of vegetative viral DNA replication was
also seen in cutaneous warts caused by HPV63 and 65
Onset of vegetative viral DNA replication and and in common warts caused by HPV2 (data not shown).
expression of E4 coincide exactly in mucosal tumors
induced by HPV16, as well as in cutaneous lesions Cells undergoing late gene expression show an
abnormal pattern of terminal differentiation comparedcaused by HPVs 1 and 63
to nonpermissive or uninfected cells
Vegetative viral DNA replication was found to begin in
cells of the midspinous layer and to correlate exactly Cells supporting the late stages of HPV infection could
thus be identified by immunostaining with Fab TVG405with the onset of E4 expression (Fig. 5). In HPV1-induced
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FIG. 3. Use of synthetic Fabs to localize HPV16 E4 protein in vivo. Immunostaining of a low-grade HPV16 CIN I with Fab NIP-C11 (Griffiths et
al., 1994), which has no reactivity toward HPV16 E4 (A), and the E4-specific Fab TVG405 which is described here (B, C, D). Fabs were detected
using 9E10 as secondary antibody followed by anti-mouse FITC conjugate. E4 is detectable in the upper layers of the epidermis but at greatly
varying levels between different lesions with often only a few positive cells being apparent (C, D). The position of the basal layer is arrowed in C
and D. Magnification, 2001.
(for HPV16), Mab 4.37 (for HPV1), or polyclonal antisera increase in size as the cell migrates toward the surface
to E4 (HPV63). In warts caused by HPV1, E4-positive cells of the skin. The E1 ò E4 protein of HPV63 was found
lacked detectable levels of filaggrin or involucrin (Fig. 6i). to have a fibrous and granular distribution. By contrast,
Nonpermissive (or uninfected) cells in the same lesion, HPV16 E4 had a filamentous and perinuclear distribution
which showed neither E4 expression nor vegetative viral in cells of the lower epidermal layers (Fig. 7) and assem-
DNA replication, expressed filaggrin and loricrin at levels bled into prominent structures only in the more differenti-
indistinguishable from those in the surrounding epider- ated cell layers. These ‘‘inclusions’’ were always found
mis. Although we could not easily detect filaggrin in CIN singly per cell (cf. multiple inclusions found in most cuta-
biopsies using our available antibodies, correlation of E4 neous lesions), were located adjacent to the nucleus,
synthesis with the differentiation-specific keratins K4 and and were nearly always detected on the side of the nu-
K13 revealed an identical pattern of inhibition. The inten- cleus closest to the surface of the epidermis. Although
sity of K4 and K13 staining was always lower in E4-
similar in appearance to the E4/intermediate filament
positive cells than in neighboring cells that were not
bundles which form after expression of the HPV16 E1 òexpressing E4 (Fig. 6ii). K5 and 14, which are present in
E4 protein in epithelial cells in vitro, we have not detectedthe basal and lower parabasal cells, were unaffected
the presence of keratins in these structures in vivo. Anti-(data not shown). This interference with the detection or
bodies to the very N-terminus of HPV16 E1 ò E4 stainedexpression of differentiation-specific keratins (K1 and
the structures much less readily than antibodies to C-K10 in cutaneous skin) was also apparent in cutaneous
terminal epitopes (TVG 404, TVG405, TVG406), sug-warts caused by HPV1 (Fig. 6ii), but interestingly was not
gesting that the N-terminal region may be either hiddenevident in warts caused by HPV63 (Fig. 6ii). The E4 pro-
or lost. Confocal imaging revealed that the N-terminaltein of HPV63 is most closely related to that of HPV1.
antibodies localize primarily at the edge of the E4 struc-
The intracellular distribution of the HPV16 E4 proteins tures while anti-C-terminal staining was strongest in the
is distinct from the distribution of E4 in cutaneous center (data not shown). When compared to the distribu-
lesions caused by HPV1 and HPV63 tion seen with TVG405 and TVG406, the anti-N-terminal
reagent revealed HPV16 E1 ò E4 to have a more diffuseThe E1 ò E4 protein of HPV1 is predominantly cyto-
plasmic and assembles into inclusions that coalesce and distribution in the cell (Fig. 8). No significant difference
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FIG. 5. Onset of vegetative viral DNA replication coincides with E4 expression in low-grade HPV16 lesions and in benign cutaneous warts. Triple
staining using the HPV16 E4 antibodies TVG402, 405, and 406 (A) and HPV1 E4 antibodies 4.37 and 9.95 (D), biotinylated DNA probe (B, HPV16;
E, HPV1), or DAPI (C and F). A, B, and C represent a section through a HPV16-induced CIN I, and D, E, and F represent a section through a HPV1-
induced verucca. In the HPV16 CIN I, vegetative viral DNA replication and E4 synthesis correlate in the middle to upper layers of the epidermis (A,
B). In cutaneous lesions the two events are initiated as soon as the infected cell leaves the basal layer (D, E). Basal cells are illustrated in the
DAPI-counterstained image (F). Magnification, 2001.
the onset of vegetative viral DNA replication coincidewas apparent among the staining patterns of TVG405,
almost exactly, not only in HPV16 and HPV1/HPV 63 le-406, 407, and the C-terminal antibody.
sions, but also in common warts caused by HPV2 and
HPV57. Second, E4 expression and the production ofDISCUSSION
virion structural proteins are not coincident. E4 expres-
Papillomavirus late gene expression is initiated as the sion precedes L1 synthesis, often by many cell layers,
infected cell migrates through the differentiating layers and in HPV16-associated CIN 2/3 lesions, E4 expression
of the epidermis. Here we have correlated events which is abundant even though the infected cells are nonper-
lead to the production of HPV16 virions in premalignant missive for virus production. And third, it is apparent that
cervical lesions and have compared these events with terminal differentiation is abnormal in cells supporting
the process of virus production in benign cutaneous HPV16 and HPV1 late gene expression, suggesting that
warts caused by HPV1 and 63. Three clear conclusions virion synthesis is not passively regulated during kera-
tinocyte differentiation. In addition, the generation ofcan be drawn from this work. First, E4 expression and
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FIG. 6. Productive infection interferes with normal epithelial terminal differentiation in low-grade HPV16 lesions and in benign cutaneous warts.
(i) Keratin expression. Triple staining using the HPV16 E4 Fabs TVG405/TVG406 (A), HPV 1 E4 monoclonals 4.37/9.95 (D), and HPV63 E4 polyclonal
antibodies (B), in conjunction with antibodies to the differentiation-specific mucosal keratins 4 and 13 (B) or cutaneous keratins 1 and 10 (E, H). C,
F, and I show the DAPI counterstain. A, B, and C represent a section through a HPV16-induced CIN I. D, E, and F show a section through the edge
of a HPV1-induced verucca, while G, H, and I show a section through a HPV63-induced wart. In HPV16 and HPV1-induced lesions, differentiation-
specific keratins are less apparent in E4-positive cells than in neighboring cells (A, B, D, E) although this was not the case with HPV63 (G, H).
Nuclear degeneration (visualized by DAPI counterstaining) is retarded in E4-expressing cells (A, C, D, F). Magnification, 2001. (ii) Filaggrin expression.
Triple staining, as described above, except that B and E show filaggrin staining. E4 staining is shown in A and D, and DAPI counterstaining is
shown in C and F. A, B, and C represent the edge of a HPV63-induced wart where normal skin (left-hand side of the panel) meets the benign tumor
(right-hand side of panel). D, E, and F show the granular layer of a HPV1-induced wart. E4-positive cells do not express detectable levels of the
differentiation-specific marker filaggrin and show marked nuclear preservation when compared to neighboring uninfected or nonpermissive cells.
Magnification, 2001.
high-affinity Fabs has allowed us to characterize HPV16 et al., 1987; Rogel-Gaillard et al., 1992). Interestingly, veg-
etative viral DNA replication can be initiated in BPV-trans-E4 and its associated structures in vivo.
E4 expression and the onset of vegetative viral DNA formed fibroblasts by serum starvation, and in these cells
high-level expression of E4 is apparent (Jareborg andreplication are among the earliest events that are detect-
able in the late stage of the HPV life cycle. It has been Burnett, 1991). While these findings and ours are compat-
ible with the suggested role for E4 in vegetative viral DNAsuggested that E4 may influence episomal copy number
by sequestering cellular factors which inhibit vegetative replication, the converse may be true. In SV40 infection,
cellular factors (IBPs) which repress the viral late pro-viral DNA replication in cells of the basal layer (Breitburd
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FIG. 6—Continued
moter (Wiley et al., 1993) are titrated out during vegetative gested by the work of Crum et al. (1990). In the most
extreme case (a cutaneous wart caused by HPV63) atviral DNA replication leading promoter activation and
synthesis of late proteins, and it has recently been sug- least 20 cell layers separated the two events. This argues
against the assumption that E4 expression is regulatedgested that vegetative viral DNA replication may be a
prerequisite for late gene expression in papillomaviruses by the same factors that control expression of L1 (Brown
et al., 1994). Phorbol esters, which are potent activators(Frattini et al., 1996). Although the molecular events
which influence vegetative viral replication appear of protein kinase C (PKC), have been shown to stimulate
L1 synthesis in HPV31-containing cell lines grown in raftclosely linked to those that regulate E4 expression, addi-
tional work will be needed to establish whether E4 stimu- culture (Meyers et al., 1992). E4 expression is unaffected
by such activators of PKC, strengthening the conclusionlates DNA replication or vice versa.
The close correlation between E4 expression and the that its regulation is distinct from that which controls
capsid synthesis (Pray and Laimins, 1995).onset of DNA replication was in contrast to the variation
observed between E4 expression and the production of The absence of filaggrin and involucrin in productively
infected cells in warts induced by HPV1 and 63 andvirion coat proteins. Expression of E4 and L1 has pre-
viously been shown to occur in similar areas in lesions the down-regulation of differentiation-specific keratins in
lesions caused by HPV16 and HPV1 suggest that HPVsinduced by HPV1, 2, 4, and 16 (Crum et al., 1990; Doorbar
et al., 1989), and the two proteins have been reported to do not depend on normal differentiation for completion
of their life cycle (see also (Rogel-Gaillard et al., 1993)).colocalize exactly in HPV11-infected foreskin implants
grown in athymic mice (Brown et al., 1994). In general, It has previously been suggested that E4 may associate
with ‘‘death proteins,’’ in order to inhibit differentiation andthese earlier studies were carried out on serial tissue
sections using polyclonal antisera, making it difficult to to allow virus production in cells that would otherwise be
dying (Rogel-Gaillard et al., 1992, 1993). Although ourdraw conclusions about E4 and L1 expression in individ-
ual cells. The double-staining approach used here has findings are compatible with such a hypothesis, recent
evidence suggests that other viral proteins may be in-revealed that E4 expression and L1 expression are not
coincident in low-grade HPV 16-induced lesions but volved. Transfection of keratinocytes with E6-expressing
plasmids leads to inhibition of calcium and serum-in-rather that E4 expression precedes that of L1 as sug-
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FIG. 7. Association of the HPV16 E4 proteins with perinuclear bundles and filamentous structures in vivo. Detection of HPV16 E4 proteins in the
upper layers (A, B) and lower layers (C, D) of a HPV16 CIN I using a mixture of Fabs TVG405 and TVG406. In the upper layers E4 is diffuse
throughout the cytoplasm but with a prominent perinuclear pattern. Concentration of E4 into perinuclear bundles (arrowed in B) is apparent in the
these cells. In the lower layers, E4 has a predominantly perinuclear and filamentous appearance (C, D), but is not concentrated into perinuclear
bundles. Magnification (A, C) 2001; (B, D) 4001.
duced terminal differentiation (Sherman and Schlegel, tein had a perinuclear distribution and was concentrated
on the side of the nucleus closest to the epithelial sur-1996; Stoppler et al., 1996). This may be manifest in vivo
as the loss of differentiation-specific antigens in cells face. Although this distribution is reminiscent of the col-
lapsed E4/keratin bundles seen following expression ofexpressing viral late proteins as observed here.
In the lower layers of naturally occurring lesions, the mucosal HPV E4 proteins in vitro (Doorbar et al., 1991,
1996a; Pray and Laimins, 1995; Roberts et al., 1993),E4 protein of HPV16 was found to have a diffuse and
filamentous appearance, while in higher layers, the pro- these structures did not stain with anti-keratin antibodies
FIG. 8. Evidence for processing of the HPV16 E4 proteins in vivo. Triple staining in the upper layers of a HPV16 CIN using HPV16E4 Fab TVG406
which recognizes an epitope in the C-terminal half of the E4 protein (A), an antibody to the N-terminal 12 amino acids of the HPV16 E1 ò E4 protein
(B), and DAPI (C). TVG402, 403, 404, 405, and 407 produced staining patterns that were not significantly different from that of TVG 406. Anti-N-
terminal antibodies did not effectively stain the perinuclear bundles (B) which were evident with TVG406 (arrowed in A), suggesting that as in HPV1,
different forms of the protein have different intracellular locations. Magnification, 4001.
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and may be similar to the prominent cytoplasmic E4 The reagents and observations described here will be
of value in these studies and should provide a standardinclusions found in HPV1 warts —which stain with kera-
tin antibodies only at their periphery (Rogel-Gaillard et to which the in vitro analysis can be compared.
al., 1993). The in vivo significance of E4s association with
keratins is uncertain, although the filamentous staining ACKNOWLEDGMENTS
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